Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Inmune Bio ( (INMB) ) just unveiled an update.
INmune Bio Inc. is set to make waves in the biotech world with its innovative platforms, XPro and INKmune, targeting neuroinflammation and cancer. XPro aims to treat Alzheimer’s by addressing it as an immunologic issue, with promising Phase 2 results expected by mid-2025. INKmune is designed to enhance NK cell functionality to combat cancer. These advancements, coupled with a strong financial backing and insider participation, position INmune Bio as a key player to watch in the financial markets.
Learn more about INMB stock on TipRanks’ Stock Analysis page.
